Doug Coyle
Coyle, Douglas
Coyle, Doug
VIAF ID: 36189032 (Personal)
Permalink: http://viaf.org/viaf/36189032
Preferred Forms
- 100 1 _ ‡a Coyle, Doug
- 100 1 _ ‡a Coyle, Doug
- 100 1 _ ‡a Coyle, Doug
-
- 100 1 _ ‡a Coyle, Douglas
-
- 100 1 _ ‡a Coyle, Douglas
- 100 0 _ ‡a Doug Coyle
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. | |
EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control | |
Estimates of effectiveness and reach for 'return on investment' modelling of smoking cessation interventions using data from England | |
Estimating the expected value of partial perfect information: a review of methods. | |
European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care. | |
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. | |
An evaluation framework for funding drugs for rare diseases | |
Evaluation of the impact of fetal fibronectin test implementation on hospital admissions for preterm labour in Ontario: a multiple baseline time-series design. | |
Exploring informed choice in the context of prenatal testing: findings from a qualitative study | |
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. | |
Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation | |
Guidelines for health technologies: specific guidance for oncology products in Canada | |
Hand Assisted Laparoscopic Surgery versus Conventional Laparoscopy for Colorectal Surgery | |
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study | |
The hidden costs and characteristics of childhood rotavirus emergency visits in Canada. | |
Impact of particulate air pollution on quality-adjusted life expectancy in Canada | |
Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: results of a randomized trial | |
The impact of risk on preference values: implications for evaluations of postmenopausal osteoporosis therapy | |
Increasing demands to consider both the benefits and costs of cancer treatment in decision relating to resource allocation | |
Increasing the methodological quality and relevance of cost effectiveness analysis | |
The Influence of Experiential Knowledge on Prenatal Screening and Testing Decisions | |
International Master's Program in health technology assessment and management: Assessment of the first edition (2001–2003) | |
Internet-based implementation of non-pharmacological interventions of the "people getting a grip on arthritis" educational program: an international online knowledge translation randomized controlled trial design protocol | |
Issues of consensus and debate for economic evaluation in rheumatology | |
Measures of importance for economic analysis based on decision modeling | |
Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada | |
Mitral Valve Clip for Treatment of Mitral Regurgitation: An Evidence-Based Analysis | |
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases | |
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. | |
Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions | |
Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis | |
Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria | |
Ottawa panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis | |
Out-of-Pocket Costs for Accessing Adjuvant Radiotherapy Among Canadian Women With Breast Cancer | |
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy | |
Pacemaker or defibrillator surgery without interruption of anticoagulation | |
Parents' perspectives on the impact of the early diagnosis of childhood hearing loss | |
Parents' preferences for services for children with hearing loss: a conjoint analysis study | |
Patient Preference-based Treatment Thresholds and Recommendations | |
Pharmacoeconomics of long-term treatment of rheumatoid arthritis | |
The problem of protocol driven costs in pharmacoeconomic analysis. | |
Program Evaluation of Hospital-Based Antenatal Home Care for High-Risk Women | |
Prospective evaluation of preferences and quality of life in women with hip fractures. | |
The psychometric properties of patient preferences in osteoporosis. | |
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. | |
Real-Time Polymerase Chain Reaction Detection of Methicillin-Resistant Staphylococcus aureus: Impact on Nosocomial Transmission and Costs | |
Reducing Periconceptional Methylmercury Exposure: Cost-Utility Analysis for a Proposed Screening Program for Women Planning a Pregnancy in Ontario, Canada | |
Reimbursement-Based Economics--What Is It and How Can We Use It to Inform Drug Policy Reform? | |
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women | |
ROI in public health policy. Supporting decision making | |
The role of models within economic analysis: focus on type 2 diabetes mellitus. | |
The Role of Pilot Studies in the Economic Evaluation of Health Technologies | |
Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B) | |
Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation | |
Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease | |
Screening for Occult Cancer in Unprovoked Venous Thromboembolism | |
Shelter-based palliative care for the homeless terminally ill. | |
Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome | |
The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada. | |
Statistical analysis in pharmacoeconomic studies. A review of current issues and standards. | |
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial | |
Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria | |
Surveillance mammography following the treatment of primary breast cancer with breast reconstruction: a systematic review | |
A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip. | |
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders | |
Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies. | |
Towards a reference case for economic evaluation of osteoporosis treatments. | |
Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations | |
Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin | |
Treatment related mortality versus quality of life--a balancing act | |
Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials. | |
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis | |
Universal vs Risk Factor Screening for Methicillin-Resistant Staphylococcus aureus in a Large Multicenter Tertiary Care Facility in Canada. | |
Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. | |
Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers. | |
Validity of standard gamble estimated quality of life in acute venous thrombosis | |
Virtual follow-up and care for patients with cardiac electronic implantable devices: protocol for a systematic review | |
Wage losses in the year after breast cancer: extent and determinants among Canadian women. | |
Welfare and policy, 1996: | |
What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review. | |
Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis | |
Who would benefit from average value-based pricing? | |
Who's better not best: appropriate probabilistic uncertainty analysis |